Feature

With the implementation of Solvency II around the corner, Silverfinch's John Dowdall sets out priorities for all insurers.

Myles Rix, managing director of protection at LV=, gives his views on how the industry can make IP more attractive in the eyes of the consumer.

As private medical insurers announce high-profile consolidations, Fiona Murphy looks at whether this restricts choice or offers a better deal for advisers and consumers.

Fergus Bescoby explains the complications of chronic kidney disease.

Justin Taurog urges the industry to go beyong measuring claim stats in promoting the worth of protection insurance.

Fergus Bescoby discusses arial fibrillation (AF), a type of heart rhythm disorder called an 'arrhythmia' which increases the risk of stroke.

Deepak Jobanputra discusses new dementia research and why advisers should be increasingly aware of clients' care needs.

The rules around Lasting Powers of Attorney are changing, making it easier for you to help your clients register and so protect their wealth in the future. And with better protection comes more opportunity for advisers writes Vitality's Justin Taurog....

Gen Re shares the results of its Protection Pulse, which identified key market trends to Q4 2014.

Munich Re's Julie Scott discusses how the critical illness industry could break the cycle of competing on conditions.